Research Technology Center, Pfizer, Inc., 620 Memorial Drive, Cambridge, MA 02139, USA. Robert.J.Chambers@pfizer.com
Abstract:
Oxindole (2) is a potent and selective PDE2 inhibitor with a favorable ADME, physiochemical and pharmacokinetic profile to allow for use as a chemical tool in elucidating the physiological role of PDE2.